Trial intelligence / Profile preview

Voclosporin versus placebo in active lupus nephritis (Phase 2, Spain)

2012-003364-51Phase 2Completed

Sponsor
Aurinia
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of voclosporin in lupus nephritis (LN) (3 arms), sponsored by Aurinia. Primary endpoint: Complete remission at Week 24. Started Jul 2014; status: completed.

02

Drugs

voclosporin
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on 2012-003364-51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003364-51.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call